Edwards Lifesciences Corp. (EW) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $85.87 -1.71%
Revenue Growth %: +11.1%
Financial Fact:
Net sales: 739.4M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +11.1%
Financial Fact:
Net sales: 739.4M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q3 EPS of $0.38, $0.01 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $412.7 million versus the consensus estimate of $405.09 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- Jabil beats consensus estimates but shares dip
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
